Financhill
Sell
47

MTD Quote, Financials, Valuation and Earnings

Last price:
$1,137.10
Seasonality move :
1.62%
Day range:
$1,145.67 - $1,174.55
52-week range:
$946.69 - $1,546.93
Dividend yield:
0%
P/E ratio:
28.82x
P/S ratio:
6.39x
P/B ratio:
--
Volume:
317.2K
Avg. volume:
233.1K
1-year change:
-16.48%
Market cap:
$24B
Revenue:
$3.9B
EPS (TTM):
$40.10

Analysts' Opinion

  • Consensus Rating
    Mettler-Toledo International has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 10 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $1,245.38, Mettler-Toledo International has an estimated upside of 7.78% from its current price of $1,155.52.
  • Price Target Downside
    According to analysts, the lowest downside price target is $1,110.00 representing 100% downside risk from its current price of $1,155.52.

Fair Value

  • According to the consensus of 14 analysts, Mettler-Toledo International has 7.78% upside to fair value with a price target of $1,245.38 per share.

MTD vs. S&P 500

  • Over the past 5 trading days, Mettler-Toledo International has underperformed the S&P 500 by -0.16% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Mettler-Toledo International does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Mettler-Toledo International revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Mettler-Toledo International reported revenues of $883.7M.

Earnings Growth

  • Mettler-Toledo International earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Mettler-Toledo International reported earnings per share of $7.81.
Enterprise value:
26B
EV / Invested capital:
13.75x
Price / LTM sales:
6.39x
EV / EBIT:
23.86x
EV / Revenue:
6.79x
PEG ratio (5yr expected):
2.31x
EV / Free cash flow:
29.95x
Price / Operating cash flow:
28.15x
Enterprise value / EBITDA:
21.46x
Gross Profit (TTM):
$2.3B
Return On Assets:
26.01%
Net Income Margin (TTM):
22.17%
Return On Equity:
--
Return On Invested Capital:
44.53%
Operating Margin:
24.84%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $4B $3.8B $3.8B $925.9M $883.7M
Gross Profit $2.3B $2.2B $2.3B $548.1M $525.9M
Operating Income $1.2B $1.1B $1.1B $249.1M $219.5M
EBITDA $1.3B $1.2B $1.2B $270.5M $248.3M
Diluted EPS $39.38 $35.66 $40.10 $8.24 $7.81
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $1.1B $1.3B $1.3B $1.2B $1.2B
Total Assets $3B $3.4B $3.4B $3.3B $3.2B
Current Liabilities $841.8M $1.1B $1B $1.1B $1.1B
Total Liabilities $2.8B $3.3B $3.4B $3.4B $3.4B
Total Equity $202.6M $84.6M -$24.5M -$158.7M -$182M
Total Debt $1.6B $1.9B $2.1B $2.1B $2.1B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations $921.5M $1B $972.8M $190M $194.4M
Cash From Investing -$154.7M -$118.2M -$117.4M -$8.9M -$6.9M
Cash From Financing -$789.2M -$901M -$861M -$179.1M -$184.1M
Free Cash Flow $796.2M $903.1M $869M $172.6M $177.2M
MTD
Sector
Market Cap
$24B
$33.4M
Price % of 52-Week High
74.7%
45.16%
Dividend Yield
0%
0%
Shareholder Yield
3.49%
-0.66%
1-Year Price Total Return
-16.48%
-40%
Beta (5-Year)
1.383
0.632
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $1,152.31
200-day SMA
Sell
Level $1,271.64
Bollinger Bands (100)
Sell
Level 1089.84 - 1306.28
Chaikin Money Flow
Buy
Level 34.7M
20-day SMA
Buy
Level $1,133.47
Relative Strength Index (RSI14)
Buy
Level 54.10
ADX Line
Buy
Level 13.55
Williams %R
Neutral
Level -37.947
50-day SMA
Buy
Level $1,106.65
MACD (12, 26)
Buy
Level 16.67
25-day Aroon Oscillator
Buy
Level 52
On Balance Volume
Neutral
Level 45.6M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (10.5228)
Sell
CA Score (Annual)
Level (-0.9722)
Buy
Beneish M-Score (Annual)
Level (-2.6206)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (2.2027)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 28%, China about 16% and the rest of the world about 19%.

Stock Forecast FAQ

In the current month, MTD has received 4 Buy ratings 10 Hold ratings, and 0 Sell ratings. The MTD average analyst price target in the past 3 months is $1,245.38.

  • Where Will Mettler-Toledo International Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Mettler-Toledo International share price will rise to $1,245.38 per share over the next 12 months.

  • What Do Analysts Say About Mettler-Toledo International?

    Analysts are divided on their view about Mettler-Toledo International share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Mettler-Toledo International is a Sell and believe this share price will drop from its current level to $1,110.00.

  • What Is Mettler-Toledo International's Price Target?

    The price target for Mettler-Toledo International over the next 1-year time period is forecast to be $1,245.38 according to 14 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 10 analysts rate the stock a Hold.

  • Is MTD A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Mettler-Toledo International is a Hold. 10 of 14 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of MTD?

    You can purchase shares of Mettler-Toledo International via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Mettler-Toledo International shares.

  • What Is The Mettler-Toledo International Share Price Today?

    Mettler-Toledo International was last trading at $1,137.10 per share. This represents the most recent stock quote for Mettler-Toledo International. Yesterday, Mettler-Toledo International closed at $1,155.52 per share.

  • How To Buy Mettler-Toledo International Stock Online?

    In order to purchase Mettler-Toledo International stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Best AI Index Fund to Buy
Best AI Index Fund to Buy

Over the last two years, companies with a focus on…

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for Jun 2

Regeneron Pharmaceuticals [REGN] is up 1.98% over the past day.

Buy
55
RGC alert for Jun 2

Regencell Bioscience Holdings [RGC] is down 12.18% over the past day.

Sell
42
AMBA alert for Jun 2

Ambarella [AMBA] is down 0.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock